LR

Mechanical Vent Chapter 4- Establishing the need for mechanical ventilation

Establishing the Need for Mechanical Ventilation

Assessing the Patient

  • Physical Examination:

    • Level of consciousness: Awake/asleep? Can they be roused and stay awake?

    • Skin Color and appearance: Warm and pink vs. cyanotic? Cool, clammy? Diaphoretic?

    • Vital Signs: HR, BP, respirations, breath sounds, and SpO2 - are they normal?

    • Mental Status: AAO x 3 (Alert and Oriented to person, place, and time)?

    • Anxiety/Agitation: Determine if anxiety alone is the problem.

  • Patient History and Diagnosis:

    • PMH (Past Medical History) and diagnosis.

    • Pre-existing pulmonary or neuromuscular diseases.

    • Traumatic injuries to head or spine.

Respiratory Failure

  • ARF (Acute Respiratory Failure): Respiratory activity is absent or insufficient for CO2 removal and O2 uptake.

    • Inability to maintain acceptable PaO2, PaCO2, and pH levels.

    • Criteria:

      • PaO2 < 70 on > 0.6 FiO2

      • PaCO2 > 55 and rising

      • pH < 7.25

  • Types of Respiratory Failure:

    • Hypoxic Respiratory Failure

    • Hypercapnic Respiratory Failure

Hypoxic Respiratory Failure
  • May not require mechanical ventilation; O2 therapy and/or CPAP may suffice.

  • Causes: V/Q mismatch, diffusion defects

Hypercapnic Respiratory Failure
  • Inability to maintain normal PaCO2.

  • Causes: CNS, neuromuscular, and WOB (Work of Breathing) disorders.

Conditions of Hypercapnia and/or Hypoxia
Hypoxia:
  • Mild to moderate:

    • Respiratory findings: Tachypnea, Dyspnea

    • Cardiovascular findings: Paleness, Tachycardia, Mild hypertension, Peripheral vasoconstriction

    • Neurological findings: Restlessness, Disorientation, Headaches, Lassitude

  • Severe:

    • Respiratory findings: Tachypnea, Dyspnea

    • Cardiovascular findings: Cyanosis, Tachycardia and eventual bradycardia, arrhythmias, Hypertension and eventual hypotension

    • Neurological findings: Somnolence, Confusion, Blurred vision, Tunnel vision, Loss of coordination, Impaired judgment, Slow reaction time, Manic-depressive activity, Coma

Hypercapnia:
  • Mild to moderate:

    • Respiratory findings: Tachypnea, Dyspnea

    • Cardiovascular findings: Tachycardia, Hypertension, Vasodilation

    • Neurological findings: Headaches, Drowsiness

  • Severe:

    • Respiratory findings: Tachypnea and eventual bradypnea

    • Cardiovascular findings: Tachycardia, Hypertension and eventual hypotension

    • Neurological findings: Hallucinations, Hypomania, Convulsions, Coma

    • Signs: Sweating, Redness of the skin.

CNS Disorders
  • Generally cause hypoventilation.

  • Causes:

    • Drugs: sedatives, narcotics, pain medications

    • Brain trauma or pathology: stroke, CHI, ICB, CVA – “Cheyne-Stokes or Biot’s” respirations

    • Pathology induced CO2 narcosis: PaCO2 > 70 mmHg acts as CNS depressant.

Neuromuscular Disorders
  • Paralytic disorders: M.G. (Myasthenia Gravis), G.B. (Guillain-Barré syndrome), Tetanus, M.S. (Multiple Sclerosis)

  • Paralytic Drugs: Succinylcholine, Norcuron, Pavulon, Zemuron, Curare, nerve gas

  • Other drugs affecting muscle function: certain antibiotics, long-term steroids

  • Impaired muscle function: electrolyte imbalances, malnutrition, air-trapping.

Increased WOB (Work of Breathing)
  • Pleural lesions: pneumo/hemothorax, effusions, empyema

  • Chest wall deformities: Trauma, obesity, kyphoscoliosis

  • Increased airway resistance: bronchospasm, mucosal edema, airway inflammation

  • Lung tissue pathology: ARDS, pulmonary edema

Physiologic Measurements

  • MIP (Maximum Inspiratory Pressure) or NIF (Negative Inspiratory Force):

    • Maximum negative pressure a patient can generate during an inspiratory effort.

    • Requires significant patient effort.

    • Indicates ability to take a deep breath.

  • VC (Vital Capacity):

    • Maximum inspiration followed by maximum expiration.

    • Indicates ability to generate a significant cough.

  • NIF and VC can be performed every 2-4 hours.

  • PEFR (Peak Expiratory Flow Rate):

    • Indicates ability to maintain adequate airway patency.

    • Routinely measured pre and post bronchodilator therapy during Asthma exacerbation.

  • RR (Respiratory Rate): Normal range is 12 – 20 breaths/min.

  • MV (Minute Ventilation): Normal range is 5 – 6 L/min.

Indications of Acute Respiratory Failure and Need for Mechanical Ventilation

Criteria

Normal Range

Critical Value*

Ventilatory mechanics

MIP (cm H₂O)

-50 to -100

0 to -20

MEP (cm H₂O)

+100

<+40

VC (mL/kg)

65-75

<15

Tidal volume (Vt) (mL/kg)

5-8

<5

Respiratory frequency (f) (breaths/min)

12-20

>35

FEV₁ (mL/kg)

50-60

<10

Ventilation

pH

7.35-7.45

<7.25

PaCO2 (mm Hg)

35-45

>55 and rising

VD/VT

0.3-0.4

>0.6

Oxygenation+

PaO2 (mm Hg)

80-100

<70 (on O₂)

P(A-a)O2 (mm Hg)

3-30

>450 (on O₂)

PaO2/FiO2

475

<200

  • Indicates need for mechanical ventilatory support.

  • Indicates need for oxygen therapy or PEEP/CPAP.

Ventilation Failure

  • PaCO2 is the best indicator of adequate ventilation.

  • Increased Dead Space: VD/VT ratio 0.3 – 0.4.

    • Dead space is an area that is ventilated but not perfused.

    • Pathological example: pulmonary embolus.

Oxygenation Failure

  • PaO2 is the best indicator of adequate oxygenation.

  • SpO2 is an acceptable non-invasive alternative (except with abnormal hemoglobin types).

  • CaO2 is a good indicator of a patient’s total oxygen carrying capacity.

    • CaO2 = (Hb \times 1.34 \times SaO2) + (PaO2 \times 0.003), normal = 19.5 vol.%

Alternatives to Invasive Ventilation

  • Oxygen Therapy, Hi-Flo O2 therapy.

  • Hi-Flow nebulizer, Heated or unheated.

  • NPPV (Non-invasive Positive Pressure Ventilation)

Objectives of Mechanical Ventilation

  • Physiological objectives

    1. To support or manipulate pulmonary gas exchange:

      • Alveolar ventilation-normal or deliberate hyperventilation (sustained hypocapnia)

      • Alveolar oxygenation-maintain oxygen delivery (CaO2 x cardiac output) at or near normal

    2. Increase lung volume:

      • Prevent or treat atelectasis with adequate end-inspiratory lung inflation

      • Achieve and maintain an adequate functional residual capacity (FRC)

    3. Reduce the work of breathing

  • Clinical objectives

    1. Reverse acute respiratory failure

    2. Reverse respiratory distress

    3. Reverse hypoxemia

    4. Prevent or reverse atelectasis

    5. Reverse ventilatory muscle fatigue

    6. Permit sedation and/or paralysis

    7. Reduce systemic or myocardial oxygen consumption

    8. Reduce intracranial pressure

    9. Stabilize the chest wall

Criteria for Mechanical Ventilation

  • Apnea or absence of breathing/airway protection

  • Acute Respiratory Failure

  • Impending Respiratory Failure

  • Refractory hypoxic Respiratory Failure with increased WOB.

  • Acute exacerbation of COPD with complicating factors.

Ethical Considerations

  • Does the patient have a “DNR” (Do Not Resuscitate) or “DNI” (Do Not Intubate) status?

  • Does the patient have an “Advanced Directive?”